Cognixion

Cognixion is a pioneering neurotech company focused on creating accessible, non-invasive brain-computer interfaces (BCIs) and assistive communication solutions. Founded in 2015 and based in Santa Barbara, California, its core platform, Axon-R, integrates EEG, eye-tracking, and AI to help individuals with severe motor impairments communicate and control their environment. The company has gained significant recognition, including FDA Breakthrough Device Designation and CMS accreditation, positioning it at the intersection of digital health, neuroscience, and accessibility technology.

Axon-R: A non-invasive, multi-modal wearable brain-computer interface (BCI) platform combining EEG-based neural signal acquisition with eye-tracking and head pose tracking. It serves as an open platform for developing AI-powered assistive and clinical applications.

Cognixion competes in the non-invasive BCI segment against companies like NextMind (acquired by Snap) and various research spin-offs. It faces indirect competition from invasive BCI leaders like Neuralink and Synchron, which offer higher fidelity signals but require surgery. In the assistive communication market, it competes with traditional AAC device makers (e.g., Tobii Dynavox) and emerging AR/VR accessibility solutions from tech giants like Apple and Meta.